Lataa...
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
Neuromyelitis optica (NMO) is an autoimmune inflammatory disease of the central nervous system with preferential involvement in the optic nerve and spinal cord with a widespread spectrum of clinical features; multiple therapeutic agents have been used with different results. Recent evidence points t...
Tallennettuna:
| Julkaisussa: | J Res Med Sci |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367207/ https://ncbi.nlm.nih.gov/pubmed/28458709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-1995.200275 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|